| typ : |
Czasopismo |
| link internetowy : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4526 |
|
| Zespoły badawcze : |
Rochester - Wegmans School of Pharmacy |
| Autorzy : |
Zhao F, Dave V.S, Mar M, Perri J. |
| Tytuł : |
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. |
| Numer : |
Int J Pharm Compound 22,5:433-439 2018 |
|
| Poziom wiarygodności : |
|
| stabilność fizyczną : |
|
| Stabilność chemiczna : |
|
| Inne metody : |
|
| Komentarze : |
|
Listy
 Eslicarbazepine acetate
|
 |
 |
 |
 |
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
 |
| 63 |
 |
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
2-8°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
